News

Friday, September 6, 2019

Beyond-use dating in the newly published USP <795> guidelines set to go into effect December 2019 have made big changes to the recommended maximum beyond-use dates for different types of formulations.

USP <800> FAQs

Tuesday, March 19, 2019

What is a hazardous drug? A hazardous drug is any drug identified as hazardous or potentially hazardous by the National Institute for Occupational Safety and Health (NIOSH) on the basis of at least one of the following six criteria: carcinogenicity...

Fagron launches new brand identity and purpose

Thursday, February 7, 2019

Fagron today launched its new brand identity, with its redefined purpose ‘Together we create the future of personalized medicine’.

Fagron, Inc. Announces New Hair Care Line - TrichoConcept™

Tuesday, August 7, 2018

Fagron, Inc. Announces New Hair Care Line - TrichoConcept™

Fagron, Inc. Extends Pharmaceutical Ingredient Supply Chain To American Pharmaceutical Ingredients' Customers

Thursday, February 1, 2018

AMERICAN PHARMACEUTICAL INGREDIENTS TO SHIFT FOCUS TO SUPPLYING US FDA APPROVED FINISHED DOSAGE DRUGS

Fagron Launches UniSpend Anhydrous

Wednesday, November 29, 2017

FAGRON, INC. INTRODUCES UNISPEND ANHYDROUS, AN INNOVATIVE ORAL SUSPENSION BASE, THAT ALLOWS FOR EASY COMPOUNDING...

FREE Webinar "On Demand" - Compounding Considerations for Autism Spectrum Disorder Patients

Tuesday, August 15, 2017

Join Fagron Academy for a short overview of Autism Spectrum Disorders and the unique patient needs

New Online Webinar Portal and CE Courses Announced

Tuesday, February 21, 2017

Fagron Academy has recently launched a new platform to host online continuing education

2017 Continuing Education for the Compounding Pharmacist Class Schedule Announced

Friday, January 27, 2017

Fagron Academy offers comprehensive experiential and lecture-based pharmacy compounding education courses. Courses provide an opportunity for participants to learn important skills and expand their knowledge base

Beyond-Use Dating Information Now Available for 5 Bases

Friday, January 20, 2017

Fagron has released beyond-use date (BUD) information for five bases including Versatile, HRT Supreme and Phytobase

Compounding Ideas for Pediatrics

Tuesday, January 10, 2017

In 2011 the Census Bureau estimated that there were 16.4 million children in the United States. One thing we know about children is, as they build their immune system they tend to get sick. Of course, children can also be hard to reason with on the

October is Breast Cancer Awareness Month, Who likes coffee?

Sunday, October 9, 2016

Purchase $750 with Fagron from Oct. 10-28th and receive two pounds of Amy’s Blend from Caribou Coffee.

Fagron ALERT: VAWD Accreditation

Sunday, September 4, 2016

Fagron, Inc. has recognized the importance of VAWD accreditation and has been VAWD accredited since 2012...

Fagron's extensive SyrSpend® SF oral suspension stability study list continues to expand to new API’s

Friday, September 2, 2016

Fagron recognizes our compounding customers’ need to have quality stability and BUD data...

Compounding for Veterinarians

Thursday, September 1, 2016

Companion animals often need medications for acute illness or long term therapies. Just like people certain pets...

Compounding for Summertime Ailments

Monday, August 1, 2016

Summertime brings heat, sunshine, sun burns, and bug bites. Summer is only a...

FREE Webinar - Compounding for Wound and Scar

Thursday, July 7, 2016

Tuesday, July 12, 2016, 12:30 - 1:30 PM EDT, Hosted by: Fagron Academy

Compounding for Wound and Scar Therapy

Friday, July 1, 2016

Wounds and scars of all types and complexities can benefit from the flexibility of compounded...

Fagron Alert: New Policy Announcement

Wednesday, June 1, 2016

New Policy: Any order less than $250 is required to use a credit card at the time of purchase.

Compounding for Alopecia

Wednesday, June 1, 2016

Alopecia is a common condition affecting men and women of all ages. It comprises hair loss, from the

Fagron Advanced Derma – ***New Innovations***

Tuesday, May 3, 2016

5 NEW INNOVATIONS added to the Fagron Advanced Derma product line.

Friday, September 4, 2015

September 16, 2015 at 11:00 am CST

Introducing Fagron Academy Compounding Technical Services (FACTS)

Monday, May 18, 2015

A new, subscription-based service offering professional and technical support

Introducing Fagron Hospital Solutions: SyrSpend® SF Convenience Packs

Monday, March 23, 2015

With a focus on patient, pharmacist, and prescriber, Fagron, Inc. offers unique solutions that add significant value in the treatment of patients with special needs.

Fagron Academy Opens, Providing Compounding and Clinical Training

Friday, January 23, 2015

$3 Million, State-of-the-Art Facility Modernizes Training

Access to Compounded Medication Coverage for 140,000 TRICARE Military Heroes and Families Clears Major Hurdle

Tuesday, January 20, 2015

Beneficiary Advisory Panel Decision Sets Stage for Continued Coverage; Final Decision Rests with TRICARE Management Activity Director

Fagron North America Applauds TRICARE Decision Supporting Access to Compounds

Tuesday, January 13, 2015

Miami, FL—Fagron North America is praising a decision last week by the TRICARE Uniform Beneficiary Advisory Panel to NOT put into effect a strict prior authorization process for compounded medication therapies.

Introducing Fagron Academy

Tuesday, January 13, 2015

Contact your Fagron Account Manager to register for Fagron Academy's: Understanding Pain Management - Therapeutic Options. February 13-14, 2015 in Atlanta, GA

NEW: Clinical study with combination pain therapy in Versatile™ Cream Base

Monday, December 29, 2014

A recent randomized, double-blind, placebo controlled study compared treatment with a combination of multiple APIs in Versatile™ cream base to Versatile™ cream base alone in patients with peripheral neuropathy(1).

NCPA 2014

Wednesday, September 10, 2014

Come visit our booth!

PAINWeek 2014

Thursday, August 28, 2014

Come visit our booth!

Stay Connected!

Wednesday, August 6, 2014

Fagron US is on Facebook, Twitter and Youtube.

Patients and Physicians for Rx Access!

Friday, June 27, 2014

Many of you have already jumped in and joined the coalition.

Save Patients' Access to Compound Medications

Monday, June 23, 2014

Join Save Rx Access!

Exclusive Fagron Advanced Derma Webinar

Wednesday, March 26, 2014

Climb to the top and join us for an Exclusive Fagron Advanced Derma Webinar

503A & 503B UPDATE

Friday, February 28, 2014

On behalf of our loyal customers, Fagron has responded to FDA's Request for Bulk Drug Substances Nominations - for both 503A & 503B Facilities.

Topical Prescription Creams Reduce Pain in Five of Every Six Chronic Pain Patients, Without Need for Opioids or Other Narcotics

Monday, November 11, 2013

Custom Compounded Prescriptions Relieve Pain; Alleviating the Need for Narcotic-Based Painkillers, Which May Reduce the "Epidemic" of Addiction

ESI/TRICARE: Important Information About Your Compounded Medications

Monday, July 29, 2013

Fagron Inc. has confirmed via the PBM responsible for TRICARE that TRICARE is evaluating the issue of pharmaceutical compounds and will delay the implementation of any change in practice on compounded prescriptions for 180 days.

Arseus: Acquisition of United States based Freedom Pharmaceuticals

Wednesday, May 22, 2013

Fagron creates a strong and nation-wide U.S. coverage, immediately delivering extra value to customers

Fagron strengthens its position in the US through the acquisition of B&B Pharmaceuticals

Thursday, December 20, 2012

Arseus announces today that it has signed an agreement to acquire B&B Pharmaceuticals

Compounders should keep the following guidelines in mind when compounding sterile preparations:

Thursday, March 22, 2012

An overview of some recommended guideline and resources for compounding sterile preparations.

U.S. Pharmaceutical Compounding Leader Gallipot Now Fagron

Tuesday, November 29, 2011

Pharmacists gain access to global expertise and supplies, and new online services

Fagron Concepts

News archive